ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

EPRX Eupraxia Pharmaceuticals Inc

3.08
-0.10 (-3.14%)
After Hours
Last Updated: 21:32:17
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
CAD ($)CAD ($)CAD ($)USD (US$)
Total Revenue 00000000
Operating Income -8.8M-4.79M-6.46M-10.51M-6.53M-6.69M-5.2M-7.63M
Pre Tax Income -9.08M-5.04M-8M-11.57M-4.32M-6.15M-6.07M-5.99M
Net Income -8.82M-5.04M-7.75M-11.34M-4.1M-6.16M-5.89M-5.94M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -8.81M-4.79M-6.46M-10.51M-7.36M-5.92M-5.2M-7.63M
EBITDA -8.75M-4.74M-6.41M-10.46M-6.67M-6.69M-5.12M-7.71M
Year End 31 December 2023 2020202120222023
CAD ($)CAD ($)CAD ($)USD (US$)
Total Revenue 0000
Operating Income -2.25M-18.68M-23.2M-27.85M
Pre Tax Income -4.01M-23.37M-23.92M-28.93M
Net Income -4.01M-22.99M-23.26M-28.22M
Preferred Dividends 0000
Basic Earnings Per Share (EPS) -0.649-1.614-1.077-1.034
EBIT -2.12M-22.21M-23.21M-28.68M
EBITDA -2.13M-18.57M-23.01M-27.85M

Your Recent History

Delayed Upgrade Clock